Original Research
Accepted on 30 Apr 2026
EZH2 Blockade Reverses Doxorubicin Resistance by Inducing Metabolic Vulnerability and Enhancing DNA Damage in Breast Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
- 147 views
6 articles related to "Tazemetostat"
Articles
Mini Review
Published on 13 May 2026
The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1843273
- 209 views
Original Research
Published on 03 Sep 2021
Lysine Methyltransferase Inhibitors Impair H4K20me2 and 53BP1 Foci in Response to DNA Damage in Sarcomas, a Synthetic Lethality Strategy
in Molecular and Cellular Oncology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2021.715126
- 6,423 views
- 12 citations
Original Research
Published on 03 Feb 2026
Integrative bulk and single-cell transcriptomics link EZH2 to immunosuppressive programs and tumor–Treg crosstalk in castration-resistant prostate cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1725097
- 1,236 views
Original Research
Published on 11 Sep 2023
Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1252658
- 4,858 views
- 8 citations
Brief Research Report
Published on 15 Apr 2026
Treatment of extracranial rhabdoid tumor with intensive ifosfamide-containing chemotherapy regimens
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1785130
- 508 views